Arabic Arabic English English French French German German
dark

Rapid Dose Therapeutics Reports Q1 Financial Results and Exercise of Warrant for Net Proceeds of $689,000

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ), today reported its Q1 financial results. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

BioLife Solutions Joins S&P SmallCap 600 Index

Next Post

Elekta to address Indonesia’s cancer care gap with direct presence

Related Posts
Total
0
Share